A Dark Vector Cognition product

Item 16. FORM 10-K SUMMARY

4K characters. Original on sec.gov ·

Item 16. FORM 10-K SUMMARY

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

INTUITIVE SURGICAL, INC.
Date:February 3, 2026By:/S/ DAVID J. ROSA
David J. Rosa Chief Executive Officer

Power of Attorney

Each person whose individual signature appears below hereby authorizes and appoints David Rosa and Jamie Samath, and each of them, with full power of substitution and re-substitution and full power to act without the other, as his or her true and lawful attorney-in-fact and agent to act in his or her name, place, and stead and to execute in the name and on behalf of each person, individually and in each capacity stated below, and to file any and all amendments to this annual report on Form 10‑K and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing, ratifying and confirming all that said attorneys-in-fact and agents or any of them or their or his substitute or substitutes may lawfully do or cause to be done by virtue thereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

SignatureTitleDate
/S/ DAVID J. ROSAChief Executive Officer and Director (Principal Executive Officer)February 3, 2026
David J. Rosa
/S/ JAMIE E. SAMATHExecutive Vice President, Chief Financial Officer (Principal Financial Officer)February 3, 2026
Jamie E. Samath
/S/ FREDRIK C. WIDMANVice President, Corporate Controller (Principal Accounting Officer)February 3, 2026
Fredrik C. Widman
/S/ GARY S. GUTHARTExecutive Chair of the Board of DirectorsFebruary 3, 2026
Gary S. Guthart, Ph.D.
/S/ CRAIG H. BARRATTLead Independent DirectorFebruary 3, 2026
Craig H. Barratt, Ph.D.
/S/ JOSEPH C. BEERYDirectorFebruary 3, 2026
Joseph C. Beery
/S/ LEWIS CHEWDirectorFebruary 3, 2026
Lewis Chew
/S/ AMAL M. JOHNSONDirectorFebruary 3, 2026
Amal M. Johnson
/S/ SREELAKSHMI KOLLIDirectorFebruary 3, 2026
Sreelakshmi Kolli
/S/ AMY L. LADDDirectorFebruary 3, 2026
Amy L. Ladd, M.D.
/S/ KEITH R. LEONARD JR.DirectorFebruary 3, 2026
Keith R. Leonard Jr.
/S/ JAMI DOVER NACHTSHEIMDirectorFebruary 3, 2026
Jami Dover Nachtsheim
/S/ MONICA P. REEDDirectorFebruary 3, 2026
Monica P. Reed, M.D.

Previous: Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULE